Assignee
SCICLONE PHARMACEUTICALS INC
US·14 granted patents·22 pending applications·169 citations·filing 1993–2023
Top patents by PatentIndex Score
36 records- 0182US9724395B2Treatment of cancer with immune stimulatorsSCICLONE PHARMACEUTICALS INC·Filed 2015·Granted Aug 8, 2017·4 cites·25 claims
- 0282US2024091314A1Use of thymosin alpha for the treatment of sepsisSCICLONE PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0379US7297676B2Thymosin alpha 1 peptide/polymer conjugatesSCICLONE PHARMACEUTICALS INC·Filed 2002·Granted Nov 20, 2007·11 cites·31 claims
- 0479US6001799AMethod of treating hepatitis C in non-responders to interferon treatmentSCICLONE PHARMACEUTICALS INC·Filed 1993·Granted Dec 14, 1999·33 cites·5 claims
- 0576US6495521B2Combination therapy method for treating chronic hepatitis BSCICLONE PHARMACEUTICALS INC·Filed 2001·Granted Dec 17, 2002·6 cites·15 claims
- 0674US5939423ATreatment of hepatitis B infection with thymosin alpha 1 and famciclovirSCICLONE PHARMACEUTICALS INC·Filed 1997·Granted Aug 17, 1999·59 cites·10 claims
- 0773US6462017B1Method of reducing side effects of chemotherapy in cancer patientsSCICLONE PHARMACEUTICALS INC·Filed 2000·Granted Oct 8, 2002·20 cites·15 claims
- 0872US7208167B2Treatment of hepatitis C with thymosin and peptide combination therapySCICLONE PHARMACEUTICALS INC·Filed 2003·Granted Apr 24, 2007·5 cites·7 claims
- 0966US8029799B2Use of thymosin alpha 1 for preparing a medicament for the treatment of stage IV malignant melanomaSCICLONE PHARMACEUTICALS INC·Filed 2009·Granted Oct 4, 2011·0 cites·6 claims
- 1066US7173013B2Treatment of tuberculosis using immunomodulator compoundsSCICLONE PHARMACEUTICALS INC·Filed 2001·Granted Feb 6, 2007·6 cites·14 claims
- 1166US2015024994A1Use of thymosin alpha for the treatment of sepsisSCICLONE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1263US7906486B2Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosaSCICLONE PHARMACEUTICALS INC·Filed 2008·Granted Mar 15, 2011·1 cites·13 claims
- 1359US7897567B2Methods of protecting against radiation damage using alpha thymosinSCICLONE PHARMACEUTICALS INC·Filed 2003·Granted Mar 1, 2011·1 cites·21 claims
- 1459US2008300166A1Treatment of Melanoma with Alpha Thymosin PeptidesSCICLONE PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 1558US2018161399A1Treatment of cancer with immune stimulatorsSCICLONE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1658US2018236036A1Use of thymosin alpha for the treatment of sepsisSCICLONE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 1758US2013296223A1Use of thymosin alpha for the treatment of sepsisSCICLONE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 1854US2010016211A1Treatment of Melanoma With Alpha Thymosin PeptidesSCICLONE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1952US2008152668A1Thymosin Alpha 1 Peptide/Polymer ConjugatesSCICLONE PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 2051US2010267637A1Treatment of melanoma with alpha thymosin peptides in combination with a kinase inhibitorSCICLONE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2150US2009074815A1Immunomodulator Compounds as Vaccine EnhancersSCICLONE PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 2250US2010092499A1Alpha Thymosin Peptides as Cancer Vaccine AdjuvantsSCICLONE PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2349US2010221274A1Method of administering a thymosin alpha 1 peptideSCICLONE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2446US6200952B1Combination therapy method for treating chronic hepatitis BSCICLONE PHARMACEUTICALS INC·Filed 1994·Granted Mar 13, 2001·10 cites·3 claims
- 2545US2011200558A1Treatment or Prevention of Hepatitis C with Immunomodulator CompoundsSCICLONE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2643US2007036744A1Treatment or prevention of respiratory viral infections with alpha thymosin peptidesSCICLONE PHARMACEUTICALS INC·Filed 2004·Application pending·0 cites
- 2743US2010204295A1Treatment of allergic disease with immunomodulator compoundsSCICLONE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 2843US2015031617A1Use of thymosin alpha for treatment of purulent rhinosinusitisSCICLONE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 2941US2007087974A1Treatment or prevention of respiratory viral infections with immunomodulator compoundsSCICLONE PHARMACEUTICALS INC·Filed 2006·Application pending·0 cites
- 3040US2010317583A1Treatment of melanoma with alpha thymosin peptides in combination with an antineoplastic heat shock apoptosis activator (hsaa)SCICLONE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3140US2010330093A1Treatment of melanoma with alpha thymosin peptides in combination with antibodies against cytotoxic t lymphocyte-associated antigen 4 (ctla4)SCICLONE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3237US6288033B1Treatment of hepatitis B infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovirSCICLONE PHARMACEUTICALS INC·Filed 1998·Granted Sep 11, 2001·12 cites·17 claims
- 3335US2011117211A1Method of Treating or Preventing Tissue Deterioration, Injury or Damage Due to Disease of MucosaSCICLONE PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
- 3433US6262230B1Analogs of thymosin α1SCICLONE PHARMACEUTICALS INC·Filed 1994·Granted Jul 17, 2001·1 cites·7 claims
- 3533US2010311656A1Treatment or prevention of respiratory viral infections with alpha thymosin peptidesSCICLONE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3621US2011245316A1Prevention or delay of onset of oral mucositisSCICLONE PHARMACEUTICALS INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SCICLONE PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →